Question 1

What is "ACAN-Smallpox antiviral"?

Accepted Answer

**PURPOSE & SCOPE:**
- **Procurement Item:** Purchase of Tembexa® (brincidofovir), an antiviral used to treat smallpox.
- **Project Scope and Objectives:** Negotiation of a contract with Emergent Biodefense Operations Lansing LLC. for the supply of the antiviral medication for public health needs managed by the Public Health Agency of Canada (PHAC).
- **Contract Type and Estimated Value:** Not specified in the provided information.

**BUYER INFORMATION:**
- **Issuing Organization:** Department of Public Works and Government Services (PSPC) on behalf of Public Services and Procurement Canada (PSPC).
- **Contact Details:** Anja Ramenason, SPAC/PSPC, Email: anja.ramenason@tpsgc-pwgsc.gc.ca
- **Important Dates:**
  - Posted Date: December 17, 2025
  - Due Date for Statements of Capabilities: January 16, 2026

**MANDATORY REQUIREMENTS:**
- **Required Certifications/Registrations:** No specific certifications or registrations mentioned.
- **Mandatory Qualifications:**
  - Supplier must be Emergent Biodefense Operations Lansing LLC. as they are the only known provider capable of delivering the required antiviral.
- **Set-Aside Requirements:** Not indicated.
- **Geographic Restrictions:** None specified.

**TECHNICAL REQUIREMENTS:**
- **Key Technical Capabilities Needed:**
  - Capable of providing a nucleotide analog DNA polymerase inhibitor specific for smallpox treatment, particularly in pediatric patients.
- **Deliverables and Performance Standards:** Specific deliverables not detailed; contract will focus on procurement, implying timely and proper supply adherence.
- **Evaluation Criteria:** Not explicitly specified in the document.

**PREFERRED QUALIFICATIONS:**
- **Nice-to-Have Certifications or Experience:** No additional preferred qualifications mentioned.
- **Additional Evaluation Factors:** Not provided.

**KEY EVALUATION FACTORS:**
- **Proposal Evaluation Method:** Unless other suppliers submit a statement of capabilities that meets requirements, contract award will proceed to the pre-identified supplier.
- **Weighting of Different Criteria:** Not mentioned.
- **Past Performance Requirements:** Not specified.

This summary highlights the critical aspects of the opportunity for potential suppliers, with a focus on matching criteria and requirements for interested parties.

Question 2

When is the proposal submission deadline?

Accepted Answer

The proposal submission deadline is January 16, 2026 (Overdue).

Question 3

Where can I submit a proposal or get solicitation documents?

Accepted Answer

You can access the full solicitation documents and submit your proposal at: https://portal.us.bn.cloud.ariba.com/dashboard/appext/comsapsbncdiscoveryui#/RfxEvent/preview/1110000734?extsite=MTExMDAwMDczNF9BTjAxNDg0MDUwOTky

ACAN-Smallpox antiviral

Actions

AI Summary

Documents

Description

Additional Information

Source

Source Record ID

Source URL

Status

Is Public

Created

Last Updated

Contact Info Name

Contact Info Email

Regions Of Delivery

Organization Address Line

Organization Address City

Organization Address Province

Organization Address Postal Code

Organization Country

Procurement Method

Selection Criteria

Source System

Reference Number

Amendment Number

Tender Closing Date

Status En

Contracting Entity Name

Procurement Category

Limited Tendering Reason

Summary Updated At